Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer

ConditionColorectal Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age20+

SponsorTaichung Veterans General Hospital

About this trial

This study aims to evaluate the survival and treatment outcomes among colorectal cancer patients undergoing anti-cancer treatment, both with and without an immunomodulator.

Eligibility criteria

Qualifiers

Aged 20 years and older.

Patients who have been given a diagnosis of colorectal cancer.

Patients had previously initiated anti-cancer therapies between January 1, 2020, and Apr 30, 2024.

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

250 Participants

are grouped into 2 trial groups

Sponsors and collaborators

Taichung Veterans General Hospital

Lead sponsor

Source ClinicalTrials.gov